Scientists crack the code of antibiotic-friendly superbug
NCT ID NCT07598006
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 56 patients in a French hospital who had infections from a rare type of Klebsiella pneumoniae bacteria that can be treated with the common antibiotic amoxicillin. Researchers used genetic sequencing to understand why these bacteria are sensitive to amoxicillin and how they relate to more dangerous strains. The goal was to learn more about these bacteria to improve future diagnosis and treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de NICE
Nice, Alpes Maritimes, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a key hormone be missing in septic shock?
- Sweat sensor could replace blood draws for sepsis monitoring
- Could a simple mineral cut the need for powerful blood-pressure drugs in septic shock?
- Experimental malaria vaccine aims to block parasite growth
- Blood filter aims to calm deadly inflammation in septic shock
- Experts unite to define sepsis care standards for Sub-Saharan africa